Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery
- 1 January 2016
- journal article
- Published by Elsevier in Biomaterials
- Vol. 74, 64-76
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81100964/H0913, 81072594, 81201071)
This publication has 59 references indexed in Scilit:
- α-Methyl-L-Tryptophan: Mechanisms for Tracer Localization of Epileptogenic Brain RegionsBiomarkers in Medicine, 2011
- Choline‐Derivate‐Modified Nanoparticles for Brain‐Targeting Gene DeliveryAdvanced Materials, 2011
- In Vivo Methods to Study Uptake of Nanoparticles into the BrainPharmaceutical Research, 2010
- Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseasesNeurobiology of Disease, 2010
- Nanotechnology for Delivery of Drugs to the Brain for EpilepsyNeurotherapeutics, 2009
- Magnetic nanoparticles in MR imaging and drug deliveryAdvanced Drug Delivery Reviews, 2008
- Functionalized magnetonanoparticles for MRI diagnosis and localization in epilepsyEpilepsia, 2008
- Microdialysis for evaluating the entrapment and release of a lipophilic drug from nanoparticlesJournal of Pharmaceutical and Biomedical Analysis, 2004
- Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanismLife Sciences, 2004
- Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in ratsEuropean Journal of Pharmacology, 2003